Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection ; volume:19 ; number:1 ; day:2 ; month:12 ; year:2019 ; pages:1-8 ; date:12.2019
BMC cancer ; 19, Heft 1 (2.12.2019), 1-8, 12.2019
- Creator
-
Tsai, Ming-Chao
Yen, Yi-Hao
Chang, Kuo-Chin
Hung, Chao-Hung
Chen, Chien-Hung
Lin, Ming-Tsung
Hu, Tsung-Hui
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6397-3
- URN
-
urn:nbn:de:101:1-2020032523571022721054
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsai, Ming-Chao
- Yen, Yi-Hao
- Chang, Kuo-Chin
- Hung, Chao-Hung
- Chen, Chien-Hung
- Lin, Ming-Tsung
- Hu, Tsung-Hui
- SpringerLink (Online service)
Other Objects (12)
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
Urokinase-type plasminogen activator receptor in vascular calcification
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)